ADJUVANT CHEMOTHERAPY OF PRIMARY OPERABLE LUMINAL B BREAST CANCER WITHOUT OVEREXPRESSION OF HER2/NEU IN POSTMENOPAUSAL WOMEN: YES OR NO?
Background. Luminal tumors account for 65 % of all breast cancer (BC) cases; however, within this group, there are multiple subtypes with various clinical and morphological characteristics, disease course and prognosis. Choosing an optimal strategy for adjuvant chemotherapy (ACT) in postmenopausal w...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2017-12-01
|
| Series: | Opuholi Ženskoj Reproduktivnoj Sistemy |
| Subjects: | |
| Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/560 |